FLUDARABIN Teva 50 mg/2ml flac 2 ml
7680585350016
CH-58535
L01BB05
07.16.1.
Reimbursement limitations:
FLUDARA
Traitement de la leucémie lymphoïde chronique (LLC) à cellules B. Le traitement de première intention …
1 / 2
google
Details
- Product number
- 5853501
- CPT
- -
- Packaging group
- 1 x 50 mg
- Unit
- Durchstechflasche(n)
- Composition
- fludarabini phosphas 50 mg, mannitolum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 3.8 mg.
Articles (1)
Fludarabin-Teva, Konzentrat zur Herstellung einer Injektions- /Infusionslösung
Konzentrat
1 x 50 mg
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 163.70
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/09/2008
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 58535
- Drug name
- Fludarabin-Teva, Konzentrat zur Herstellung einer Injektions- /Infusionslösung
- Galenic form
- KOIN
- ATC Code
- L01BB05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/06/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUDARABIN Teva 50 mg/2ml flac 2 ml
- Description (DE)
- FLUDARABIN Teva 50 mg/2ml Durchstf 2 ml
- Market launch
- 20/06/2008
- Narcotic (BTM)
- No